Footmotion Plating System

K221395 · Newclip Technics · HRS · Jul 1, 2022 · Orthopedic

Device Facts

Record IDK221395
Device NameFootmotion Plating System
ApplicantNewclip Technics
Product CodeHRS · Orthopedic
Decision DateJul 1, 2022
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 888.3030
Device ClassClass 2
AttributesTherapeutic

Intended Use

The implants of the Footmotion Plating System are intended for arthrodeses, fractures and osteotomies fixation and revision surgeries of the foot in adults.

Device Story

The Footmotion Plating System consists of metallic bone plates and screws used for internal fixation in foot surgery. The system is designed for use by orthopedic surgeons in clinical settings to stabilize bone segments during arthrodesis, fracture repair, or osteotomy procedures. Implants are provided either non-sterile (requiring sterilization by healthcare professionals) or sterile (via gamma sterilization). The surgeon selects appropriate plates and screws based on the anatomical site and clinical requirements to achieve rigid fixation. The device provides mechanical support to the bone, facilitating healing and alignment, which benefits the patient by restoring structural integrity to the foot.

Clinical Evidence

No clinical studies were performed. Substantial equivalence is supported by non-clinical bench testing, including 4-point bending tests (ASTM F382), torsional testing (ASTM F543), and axial pull-out strength analysis per FDA guidance.

Technological Characteristics

Materials: CP Titanium (ASTM F67, ISO 5832-2) and Ti-6Al-4V ELI Titanium alloy (ASTM F136, ISO 5832-3). Mechanical fixation via plates and screws. Sterilization: Gamma radiation or steam sterilization by end-user. No software or electronic components.

Indications for Use

Indicated for arthrodeses, fractures, osteotomies fixation, and revision surgeries of the foot in adults.

Regulatory Classification

Identification

Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ July 1, 2022 Image /page/0/Picture/1 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue. Newclip Technics % J.D. Webb Official Correspondent The OrthoMedix Group, Inc 1001 Oakwood Blvd Round Rock, Texas 78681 Re: K221395 Trade/Device Name: Footmotion Plating System Regulation Number: 21 CFR 888.3030 Regulation Name: Single/Multiple Component Metallic Bone Fixation Appliances And Accessories Regulatory Class: Class II Product Code: HRS, HWC Dated: May 11, 2022 Received: May 13, 2022 Dear J.D. Webb: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's {1}------------------------------------------------ requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, For: Shumaya Ali, M.P.H. Assistant Director DHT6A: Division of Restorative, Repair and Trauma Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ # Indications for Use 510(k) Number (if known) K221395 Device Name Footmotion Plating System Indications for Use (Describe) The implants of the Footmotion Plating System are intended for arthrodeses, fractures and osteotomies fixation and revision surgeries of the foot in adults. Type of Use (Select one or both, as applicable)X Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C) #### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. #### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ Image /page/3/Picture/0 description: The image shows the logo for New Clip-Technics. The logo features the letters "nct" in a stylized, lowercase font, with a red arrow pointing upwards replacing the top of the "t". The letters are enclosed in a black circle. Below the circle, the words "NEW CLIP-TECHNICS" are written in a bold, sans-serif font, with a hyphen separating "CLIP" and "TECHNICS". K221395 Page 1 of 4 #### 510 (k) Summary for the Footmotion Plating System 4. In accordance with 21 CFR 807.92 of the Federal Code of Regulations, the following 510(k) summary is submitted for the Footmotion Plating System. Summary preparation date: April 29, 2022 #### 1. Submitter: #### Contact Person: NEWCLIP TECHNICS P.A. de la Lande Saint Martin 45 rue des Garottières F-44115 Haute-Goulaine - France Telephone: (33) 2 28 21 37 12 J.D. Webb The OrthoMedix Group, Inc. 4313 W. 3800 S. West Haven. UT 84401 Telephone: 512-590-5810 | 2. Trade name: | Footmotion Plating System | |----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Common Name: | Plate, Fixation, Bone / Screw, Fixation, bone | | Product code: | HRS - Plate, Fixation, Bone<br>HWC - Screw, Fixation, Bone | | Classification Name: | Single/multiple component metallic bone fixation<br>appliances and accessories. (21 CFR part. 888.3030)<br>Smooth or threaded metallic bone fixation fastener.(21<br>CFR part. 888.3040) | {4}------------------------------------------------ Image /page/4/Picture/1 description: The image shows the logo for New Clip-Technics. The logo features the letters "nct" in a stylized, lowercase font, with the "t" having an upward-pointing arrow as its vertical component. The letters are enclosed within a black circle. Below the circle, the words "NEW CLIP-TECHNICS" are written in a sans-serif font, with a hyphen separating "CLIP" and "TECHNICS". #### 3. Primary predicate or legally marketed devices which are substantially equivalent: - Footmotion Plating System of Newclip Technics (K161448 / K171510) ● #### Additional predicate or legally marketed devices which are substantially equivalent: - Ortholoc® 3Di Midfoot/Flatfoot System of Wright Medical Technology ● (K121651). - DARCO Locking Bone Plate System of Wright Medical Technology ● (K061808), - A.L.P.S Calcaneal Plating System of Biomet (K132898), - Gorilla® Plating System of Paragon28 (K190365), ● - ActivAnkle (K143061/K173641) of Newclip Technics. ● - 4. Description of the device: The Footmotion Plating System consists of plates and screws, designed for arthrodeses, fractures and osteotomies fixation and revision surgeries of the foot in adults. The implants of the Footmotion Plating System will be provided non sterile for sterilization by health care professionals prior to use, or provided sterile by gamma sterilization. The instruments of the Footmotion Plating System will be provided non sterile for sterilization by health care professionals prior to use. - CP Titanium (conform to ASTM F67 and ISO Materials: 5832-2) and Titanium alloy Ti-6Al-4V ELI (conform to ASTM F136 and ISO 5832-3). - The implants of the Footmotion Plating System Function: are intended for arthrodeses, fractures and osteotomies fixation and revision surgeries of the foot in adults. {5}------------------------------------------------ K221395 Page 3 of 4 Image /page/5/Picture/1 description: The image shows the logo for Newclip-Technics. The logo consists of the letters "nct" inside of a circle. The "t" in "nct" has a red arrow pointing upwards. Below the circle, the words "NEWCLIP-TECHNICS" are written in all caps. #### 5. Substantial equivalence claimed to predicate devices: The Footmotion Plating System is substantially equivalent to the predicate devices in terms of intended use, design, materials used, mechanical safety and performance. ## 6. Intended use: The implants of the Footmotion Plating System are intended for arthrodeses, fractures and osteotomies fixation and revision surgeries of the foot in adults. #### 7. Summary of the technological characteristics compared to predicate #### Intended Use The implants of the Footmotion Plating System are intended for arthrodeses, fractures and osteotomies fixation and revision surgeries of the foot in adults. #### Indications for Use All of the devices comply with the indications for use specified in 21 CFR section 888.3030 for metallic bone fixation devices. #### Material The Footmotion Plating System uses the same material as the predicate devices. #### Design The Footmotion Plating System and the predicates are equivalent in terms of shape, material, and operating principles. #### Sizes The Footmotion Plating System and the predicates are equivalent in their dimensions. #### 8. Non-clinical Test Summary: The following tests were conducted: 1. 4-point-bending tests per ASTM F382 were conducted to compare the bending strength of the subiect device plates to the predicates. 2. ASTM F543 torsional testing was performed on the subject screws. Equation described by Chapman for axial pull-out strength was performed on the subject screws (FDA-Guidance: Orthopedic Non-Spinal Metallic Bone Screws and Washers - Performance Criteria for Safety and Performance Based Pathway-2020). {6}------------------------------------------------ Image /page/6/Picture/0 description: The image shows a logo for "NEWCLIP-TECHNICS". The logo consists of a circle containing the letters "nc" in a stylized font, with a red arrow pointing upwards replacing the right side of the "t". Below the circle, the words "NEWCLIP-TECHNICS" are written in a sans-serif font, with hyphens separating the words. 3. Endotoxin testing is performed using LAL quantitative kinetic chromogenic method. The analysis showed that the Footmotion Plating System is substantially equivalent to cleared predicates. ## 9. Clinical Test Summary: No clinical studies were performed. ## 10. Conclusions Non-clinical and clinical: Based on the indications for use, technological characteristics, and the summary of data submitted, Newclip Technics determined that the Footmotion Plating System is substantially equivalent to the cleared predicate devices listed above.
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%